Lung Cancers Terminated Phase 2 Trials for PR-104 (DB05968)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00544674PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung CancerTreatment